Labor Market Pulse ArchiveSubscribe to a report

Labor Market Pulse · Life Sciences · September 2026

Life Sciences Labor Market Report: Barnstable Town, MA MSA — September 2026

Barnstable's regulatory pay cools while clinical research heats up.

Advertised Regulatory Affairs Specialist pay fell to $117,616 in the Barnstable metro even as Clinical Research Associate pay climbed to $82,266, against a county unemployment rate still a point above last year's 4.3%.

Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.

Key indicators

  • County unemployment rate: 5.5% — Down from 5.8% in July, up from 4.3% a year ago
  • Regulatory Affairs Specialist pay: $117,616 — Down moderately; national median stable near $104,000
  • Massachusetts R&D job losses, 2025: 2,563 jobs — Steepest decline among major U.S. R&D hubs
  • MA biomanufacturing employment: 10,311 workers — vs 41,902 in California

Key takeaways

Regulatory affairs pay cooled locally while clinical research pay climbed.

Advertised Regulatory Affairs Specialist pay dropped to $117,616 against a stable national median near $104,000, while CRA pay rose to $82,266 locally versus $90,956 nationally. Diverging trajectories within the same metro suggest employers are reprioritizing clinical execution talent over regulatory headcount this cycle.

Seasonal unemployment swings mask a tighter specialist labor pool.

County unemployment eased month-over-month to 5.5% but remains a full point above last year's 4.3%, reflecting tourism-driven seasonal hiring rather than genuine slack in scientific or regulatory talent. Leaders should treat headline unemployment improvement with caution when assessing candidate availability for credentialed roles.

Statewide R&D job losses widen the Cape's talent sourcing gap.

Massachusetts lost 2,563 R&D positions in 2025, the steepest decline among major U.S. research hubs, compounding Barnstable's already thin specialized labor supply outside Boston-Cambridge. Organizations may need to rely more heavily on relocation incentives or remote/hybrid clinical and regulatory roles to compete for scarce talent.

Lab technician pay softened even as national rates also declined.

Metro lab technician pay fell to $52,500, tracking a national decline to $47,402 but still commanding a notable premium over the national figure. Persistent premium despite falling demand signals Cape Cod employers are still paying for scarcity, not easing standards.

Median advertised pay by role — Barnstable Town, MA MSA

Life Sciences roles, September 2026. Source: WageScape.
Role25th percentileMedian advertised pay75th percentileMetro trendNational median
Research Scientist *$113,536$142,638$153,000Significant increase$131,354
Clinical Research Associate *$58,868$82,266$98,500Significant increase$90,956
Lab Technician *$43,544$52,500$57,433Moderate decline$47,402
Regulatory Affairs Specialist *$84,083$117,616$129,350Moderate decline$104,000
Clinical Data Manager *$100,353$123,031$145,187Moderate decline$123,031
Biostatistician *$107,561$147,083$165,000Moderate increase$133,322
Validation Engineer *$95,510$114,868$124,869Moderate increase$108,377

* State-level figure shown where metro postings were too few.

WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON

Local market conditions

Barnstable County unemployment sits at 5.5% in August, down from July's 5.8% but up sharply from 4.3% a year earlier — a seasonal tourism-driven swing that leaves the Cape's labor pool thinner for specialized science roles than headline improvement suggests. Regulatory Affairs Specialist advertised pay fell to $117,616 even as national pay held stable near $104,000, while Clinical Research Associate pay rose to $82,266 locally, pointing to uneven, role-specific demand rather than broad-based market loosening.

What it means

Divergent local pay signals — regulatory affairs cooling, clinical research heating up — suggest Barnstable-area employers face a bifurcated talent market where consolidation pressure in some functions coexists with genuine scarcity in others, complicating flat headcount assumptions. With Massachusetts having shed 2,563 R&D jobs statewide in 2025 and biomanufacturing capacity still a fraction of California's, Cape-based organizations weighing clinical trial or quality headcount against CRO support should factor in a shallower regional bench than Boston-Cambridge comparisons imply. Consider reviewing whether Barnstable-based regulatory and clinical roles are being benchmarked against statewide Boston-anchored data that may overstate local pay competitiveness.

Looking ahead

Expected release: September unemployment and wage data for Barnstable Town publish October 20, 2026, offering the first real read on whether seasonal tourism contraction is deepening or stabilizing. Watch whether the gap versus last year's 4.3% narrows or widens before finalizing Q4 headcount plans.

Emerging pressure point: Massachusetts manufacturing added only 238 biomanufacturing jobs in 2025 against California's 41,902-employee base, underscoring thin regional CDMO capacity. Cape-area organizations evaluating build-versus-outsource manufacturing decisions should monitor whether statewide capacity investment reaches the Cape or remains concentrated in Cambridge-Boston corridors.

Worth watching: Massachusetts WARN filings are down 11% year-over-year statewide, but healthcare and manufacturing remain the most-cited sectors. Any Cape-based hospital or manufacturing notice could release clinical or quality talent into the local pool worth monitoring for opportunistic hiring.

Early indicator: Sanofi's 385 new Massachusetts hires in 2026 signal selective statewide biopharma expansion after 2025 consolidation. Track whether this hiring momentum extends beyond Cambridge-anchored employers to Cape-adjacent clinical and CRO operations competing for the same regulatory and clinical talent pool.

Methodology

Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.

Free to read and cite with attribution to WageScape. Terms of use.